NYSE:EPAM - EPAM Systems Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $445.50
  • Forecasted Upside: -12.74 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
▼ -4.08 (-0.79%)
1 month | 3 months | 12 months
Get New EPAM Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EPAM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EPAM

Average Price Target: $445.50
▼ -12.74% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for EPAM Systems in the last 3 months. The average price target is $445.50, with a high forecast of $525.00 and a low forecast of $356.00. The average price target represents a -12.74% upside from the last price of $510.52.


The current consensus among 10 investment analysts is to buy stock in EPAM Systems. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/10/2021Morgan StanleyBoost Price TargetOverweight$467.00 ➝ $510.00Low
5/10/2021Piper SandlerBoost Price TargetOverweight$507.00 ➝ $517.00Low
5/10/2021BarclaysBoost Price TargetOverweight$450.00 ➝ $521.00Low
5/6/2021Needham & Company LLCBoost Price TargetBuy$460.00 ➝ $525.00Low
5/4/2021Morgan StanleyBoost Price TargetOverweight$450.00 ➝ $467.00Low
5/3/2021Piper SandlerBoost Price TargetOverweight$442.00 ➝ $507.00Low
4/19/2021VTB CapitalReiterated RatingBuy ➝ Hold$425.00High
4/12/2021VTB CapitalDowngradeBuy ➝ Hold$425.00Medium
3/9/2021VTB CapitalUpgradeHold ➝ BuyHigh
2/25/2021Morgan StanleyBoost Price TargetOverweight$433.00 ➝ $450.00Low
2/22/2021BarclaysBoost Price TargetOverweight$377.00 ➝ $450.00High
2/19/2021CitigroupBoost Price Target$415.00 ➝ $440.00Low
2/19/2021Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$395.00 ➝ $440.00Low
2/19/2021Piper SandlerBoost Price TargetOverweight$404.00 ➝ $442.00Low
2/17/2021Morgan StanleyBoost Price TargetOverweight$429.00 ➝ $433.00Low
1/29/2021Morgan StanleyBoost Price TargetOverweight$392.00 ➝ $429.00Low
1/18/2021VTB CapitalUpgradeSell ➝ Hold$350.00N/A
12/18/2020Wells Fargo & CompanyInitiated CoverageOverweightLow
11/12/2020Bank of AmericaUpgradeNeutral ➝ Buy$364.00Low
11/6/2020Morgan StanleyBoost Price TargetOverweight$390.00 ➝ $392.00Low
10/13/2020Morgan StanleyBoost Price TargetOverweight$370.00 ➝ $390.00Low
10/5/2020BarclaysBoost Price TargetOverweight$342.00 ➝ $369.00Medium
9/30/2020Morgan StanleyBoost Price TargetOverweight$349.00 ➝ $370.00Medium
8/27/2020Needham & Company LLCBoost Price TargetBuy$350.00 ➝ $370.00Low
8/17/2020JPMorgan Chase & Co.Boost Price TargetAverage ➝ Overweight$240.00 ➝ $356.00Low
8/12/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$246.00 ➝ $349.00High
8/6/2020Stifel NicolausBoost Price TargetBuy$275.00 ➝ $357.00Low
8/6/2020Needham & Company LLCBoost Price TargetBuy$265.00 ➝ $350.00Low
8/5/2020VTB CapitalDowngradeHold ➝ SellLow
7/28/2020Piper SandlerBoost Price TargetOverweight$258.00 ➝ $300.00Medium
7/17/2020CitigroupBoost Price TargetBuy$265.00 ➝ $305.00Medium
6/15/2020Morgan StanleyInitiated CoverageEqual Weight$246.00Medium
5/21/2020Piper SandlerInitiated CoverageOverweight$258.00Low
5/8/2020CitigroupBoost Price TargetBuy$245.00 ➝ $265.00Medium
5/8/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$220.00Medium
5/7/2020Needham & Company LLCBoost Price TargetBuy$200.00 ➝ $265.00Medium
5/7/2020Cantor FitzgeraldLower Price TargetOverweight$260.00 ➝ $249.00Medium
4/29/2020CitigroupBoost Price TargetBuy$225.00 ➝ $245.00Low
4/24/2020Susquehanna BancsharesDowngradePositive ➝ Neutral$274.00 ➝ $230.00Low
4/14/2020Wells Fargo & CompanyLower Price TargetOverweight$265.00 ➝ $220.00Low
4/13/2020CowenLower Price TargetOutperform$260.00 ➝ $225.00Medium
3/20/2020Needham & Company LLCLower Price TargetBuy$285.00 ➝ $200.00Low
3/13/2020VTB CapitalUpgradeSell ➝ HoldHigh
3/11/2020JPMorgan Chase & Co.Boost Price TargetOverweight$247.00 ➝ $249.00High
2/24/2020BarclaysBoost Price TargetOverweight$254.00 ➝ $272.00Low
2/21/2020KeyCorpBoost Price TargetOverweight$252.00 ➝ $267.00High
2/21/2020Cantor FitzgeraldBoost Price TargetOverweight$219.00 ➝ $260.00High
2/21/2020CitigroupBoost Price TargetBuy$263.00 ➝ $274.00High
2/20/2020Needham & Company LLCBoost Price TargetBuy$235.00 ➝ $285.00Low
1/15/2020CitigroupBoost Price TargetBuy$230.00 ➝ $263.00Low
1/13/2020WedbushBoost Price TargetOutperform$220.00 ➝ $235.00Medium
1/13/2020KeyCorpBoost Price TargetOverweight$213.00 ➝ $252.00Medium
1/9/2020Wells Fargo & CompanyBoost Price TargetOverweight$222.00 ➝ $244.00Low
1/6/2020Wolfe ResearchDowngradeOutperform ➝ Peer PerformMedium
11/22/2019CowenReiterated RatingOutperform$215.00 ➝ $225.00Low
11/22/2019Needham & Company LLCBoost Price TargetBuy$220.00 ➝ $235.00Low
11/14/2019Wells Fargo & CompanyInitiated CoverageOutperform$222.00High
11/8/2019Cantor FitzgeraldBoost Price TargetOverweight$212.00 ➝ $219.00Low
11/7/2019Needham & Company LLCReiterated RatingBuy$220.00Low
9/20/2019BarclaysInitiated CoverageOverweight$214.00Low
8/9/2019Cantor FitzgeraldBoost Price TargetOverweight$187.00 ➝ $212.00Medium
7/24/2019CowenBoost Price TargetOutperform ➝ Positive$180.00 ➝ $210.00Low
5/8/2019WedbushReiterated RatingOutperform$158.00 ➝ $180.00Low
2/15/2019JPMorgan Chase & Co.Boost Price TargetOverweight$167.00N/A
2/15/2019VTB CapitalDowngradeHold ➝ SellLow
2/13/2019WedbushBoost Price TargetOutperform ➝ Outperform$150.00 ➝ $158.00Low
2/11/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$144.00 ➝ $164.00Medium
2/11/2019SunTrust BanksBoost Price TargetPositive ➝ Buy$165.00Medium
11/20/2018Jefferies Financial GroupInitiated CoverageHold ➝ Hold$134.00Medium
11/2/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$152.00 ➝ $157.00Low
11/2/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$139.00 ➝ $146.00Low
11/2/2018KeyCorpLower Price TargetOverweight ➝ Overweight$146.00 ➝ $144.00Low
10/5/2018CitigroupBoost Price TargetBuy ➝ Buy$142.00 ➝ $153.00Low
9/4/2018Bank of AmericaDowngradeBuy ➝ Neutral$134.00 ➝ $147.00Low
8/21/2018WedbushBoost Price TargetOutperform$135.00 ➝ $150.00Low
8/3/2018SunTrust BanksReiterated RatingBuy$138.00Medium
8/2/2018Cantor FitzgeraldReiterated RatingBuy$139.00High
7/30/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$143.00 ➝ $149.00Low
7/17/2018Wolfe ResearchInitiated CoverageOutperformLow
5/17/2018CowenBoost Price TargetOutperform$130.00 ➝ $145.00Low
5/10/2018Berenberg BankBoost Price Target$145.00High
5/9/2018Cantor FitzgeraldReiterated RatingBuy$139.00High
5/7/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$132.00Medium
4/19/2018SunTrust BanksInitiated CoverageBuy ➝ Buy$130.00Medium
3/19/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$130.00 ➝ $135.00Low
3/16/2018JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Overweight$118.00 ➝ $130.00Medium
2/20/2018Needham & Company LLCBoost Price TargetBuy$130.00Low
2/20/2018KeyCorpReiterated RatingOverweight ➝ Overweight$123.00 ➝ $132.00Low
2/20/2018Credit Suisse GroupDowngradeOutperform ➝ Neutral$113.85 ➝ $130.00Low
2/19/2018Cantor FitzgeraldBoost Price TargetOverweight$130.00Low
2/16/2018Stifel NicolausReiterated RatingBuy ➝ Buy$105.00 ➝ $135.00Low
2/16/2018Pivotal ResearchSet Price TargetBuy ➝ Buy$120.00 ➝ $135.00Low
12/11/2017CowenSet Price TargetBuy$115.00Medium
12/5/2017Pivotal ResearchInitiated CoverageBuy ➝ Buy$120.00Low
11/29/2017UBS GroupDowngradeBuy ➝ Neutral$105.00 ➝ $110.00High
11/6/2017Bank of AmericaBoost Price TargetBuy$95.00 ➝ $110.00N/A
11/3/2017CitigroupBoost Price TargetBuy$105.00 ➝ $110.00N/A
11/3/2017Needham & Company LLCReiterated RatingBuy ➝ Buy$90.00 ➝ $110.00N/A
11/3/2017UBS GroupReiterated RatingBuy$96.00 ➝ $105.00N/A
11/2/2017Cantor FitzgeraldReiterated RatingBuy$92.00N/A
10/29/2017KeyCorpReiterated RatingBuy$100.00N/A
10/20/2017KeyCorpReiterated RatingBuyN/A
10/13/2017CitigroupBoost Price TargetBuy$96.00 ➝ $105.00N/A
10/12/2017CowenReiterated RatingBuy$95.00N/A
9/13/2017KeyCorpBoost Price TargetOverweight$90.00 ➝ $94.00Medium
9/12/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$95.00High
9/1/2017CowenReiterated RatingBuy$95.00Medium
8/17/2017Jefferies Financial GroupSet Price TargetBuy$95.00Low
8/6/2017Berenberg BankSet Price TargetBuy$95.00Low
8/4/2017BarclaysLower Price TargetOverweight$92.00 ➝ $91.00Low
8/4/2017UBS GroupBoost Price TargetBuy ➝ Buy$89.00 ➝ $96.00Low
7/4/2017Credit Suisse GroupInitiated CoverageOutperform$90.00Low
5/15/2017WedbushBoost Price TargetOutperform$82.00 ➝ $90.00N/A
5/15/2017BarclaysBoost Price TargetOverweight$80.00 ➝ $84.00N/A
5/10/2017Monness Crespi & HardtBoost Price TargetBuy ➝ Buy$82.00 ➝ $91.00Low
5/8/2017WedbushBoost Price TargetOutperform ➝ Outperform$82.00 ➝ $90.00Low
5/5/2017BarclaysReiterated RatingOverweight$80.00 ➝ $84.00Low
5/5/2017Needham & Company LLCReiterated RatingBuy$82.00 ➝ $90.00Low
5/4/2017Cantor FitzgeraldReiterated RatingBuy$78.00High
4/7/2017Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$90.00Low
3/9/2017Monness Crespi & HardtBoost Price TargetBuy ➝ Buy$75.00 ➝ $82.00Low
2/19/2017BarclaysReiterated RatingBuyN/A
2/17/2017Cantor FitzgeraldBoost Price TargetOverweight$68.00 ➝ $78.00N/A
2/16/2017Needham & Company LLCBoost Price TargetBuy$75.00 ➝ $82.00N/A
11/8/2016BarclaysReiterated RatingEqual Weight$75.00 ➝ $70.00N/A
11/8/2016Needham & Company LLCLower Price TargetBuy$82.00 ➝ $75.00N/A
10/20/2016Monness Crespi & HardtUpgradeNeutral ➝ Buy$75.00N/A
9/12/2016Cantor FitzgeraldReiterated RatingBuy$75.00N/A
9/8/2016WedbushInitiated CoverageOutperform$82.00N/A
8/22/2016Cantor FitzgeraldReiterated RatingBuyN/A
8/5/2016Pacific CrestReiterated RatingBuy$77.00N/A
7/12/2016UBS GroupReiterated RatingBuy$80.00 ➝ $74.00N/A
7/12/2016Pacific CrestInitiated CoverageOverweight$77.00N/A
7/9/2016CitigroupReiterated RatingBuyN/A
7/7/2016BarclaysLower Price TargetEqual Weight$85.00 ➝ $75.00N/A
7/5/2016Cantor FitzgeraldReiterated RatingBuy$84.00N/A
(Data available from 6/20/2016 forward)
EPAM Systems logo
EPAM Systems, Inc. provides digital platform engineering and software development services in North America, Europe, Russia, Belarus, Kazakhstan, Ukraine, Georgia, East Asia, Southeast Asia, and Australia. The company offers engineering services, including requirements analysis and platform selection, customization, cross-platform migration, implementation, and integration; infrastructure management services, such as software development, testing, and maintenance with private, public, and mobile infrastructures for application, database, network, server, storage, and systems operations management, as well as monitoring, incident notification, and resolution services; and maintenance and support services. It also provides operation solutions comprising integrated engineering practices and smart automation; and optimization solutions that include software application testing, test management, automation, and consulting services to enable customers enhance their existing software testing and quality assurance practices, as well as other testing services that identify threats and close loopholes to protect its customers' business systems from information loss. In addition, the company offers business, experience, technology, data, and technical advisory consulting services; and digital and service design solutions, which comprise strategy, design, creative, and program management services, as well as physical product development. It serves the financial services, travel and consumer, software and hi-tech, business information and media, life sciences and healthcare, and other industries. EPAM Systems, Inc. has a partnership with Curogram to help healthcare systems implement a simplified COVID-19 crisis response solution. The company was founded in 1993 and is headquartered in Newtown, Pennsylvania.
Read More

Today's Range

Now: $510.52
Low: $510.21
High: $521.86

50 Day Range

MA: $467.60
Low: $424.67
High: $514.60

52 Week Range

Now: $510.52
Low: $239.61
High: $521.86


389,432 shs

Average Volume

315,195 shs

Market Capitalization

$28.80 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of EPAM Systems?

The following sell-side analysts have issued stock ratings on EPAM Systems in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Piper Sandler, Stifel Nicolaus, VTB Capital, and Wells Fargo & Company.
View the latest analyst ratings for EPAM.

What is the current price target for EPAM Systems?

10 Wall Street analysts have set twelve-month price targets for EPAM Systems in the last year. Their average twelve-month price target is $445.50, suggesting a possible downside of 12.7%. Needham & Company LLC has the highest price target set, predicting EPAM will reach $525.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $356.00 for EPAM Systems in the next year.
View the latest price targets for EPAM.

What is the current consensus analyst rating for EPAM Systems?

EPAM Systems currently has 1 hold rating and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EPAM will outperform the market and that investors should add to their positions of EPAM Systems.
View the latest ratings for EPAM.

What other companies compete with EPAM Systems?

How do I contact EPAM Systems' investor relations team?

EPAM Systems' physical mailing address is 41 UNIVERSITY DRIVE SUITE 202, NEWTOWN PA, 18940. The information technology services provider's listed phone number is 267-759-9000 and its investor relations email address is [email protected] The official website for EPAM Systems is www.epam.com.